These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 29574749)
21. Cutaneous side effects of inhibitors of the RAS/RAF/MEK/ERK signalling pathway and their management. Manousaridis I; Mavridou S; Goerdt S; Leverkus M; Utikal J J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):11-8. PubMed ID: 22540151 [TBL] [Abstract][Full Text] [Related]
22. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway. Gollob JA; Wilhelm S; Carter C; Kelley SL Semin Oncol; 2006 Aug; 33(4):392-406. PubMed ID: 16890795 [TBL] [Abstract][Full Text] [Related]
23. Targeting RAS-RAF-MEK-ERK signaling pathway in human cancer: Current status in clinical trials. Song Y; Bi Z; Liu Y; Qin F; Wei Y; Wei X Genes Dis; 2023 Jan; 10(1):76-88. PubMed ID: 37013062 [TBL] [Abstract][Full Text] [Related]
24. Paradoxical activation of MEK/ERK signaling induced by B-Raf inhibition enhances DR5 expression and DR5 activation-induced apoptosis in Ras-mutant cancer cells. Oh YT; Deng J; Yue P; Sun SY Sci Rep; 2016 May; 6():26803. PubMed ID: 27222248 [TBL] [Abstract][Full Text] [Related]
25. Coxsackievirus B3 induces autophagy in HeLa cells via the AMPK/MEK/ERK and Ras/Raf/MEK/ERK signaling pathways. Xin L; Ma X; Xiao Z; Yao H; Liu Z Infect Genet Evol; 2015 Dec; 36():46-54. PubMed ID: 26305625 [TBL] [Abstract][Full Text] [Related]
26. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Chang F; Steelman LS; Lee JT; Shelton JG; Navolanic PM; Blalock WL; Franklin RA; McCubrey JA Leukemia; 2003 Jul; 17(7):1263-93. PubMed ID: 12835716 [TBL] [Abstract][Full Text] [Related]
27. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines. Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493 [TBL] [Abstract][Full Text] [Related]
28. MEK in cancer and cancer therapy. Neuzillet C; Tijeras-Raballand A; de Mestier L; Cros J; Faivre S; Raymond E Pharmacol Ther; 2014 Feb; 141(2):160-71. PubMed ID: 24121058 [TBL] [Abstract][Full Text] [Related]
29. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism. Romerio F; Riva A; Zella D Br J Cancer; 2000 Aug; 83(4):532-8. PubMed ID: 10945503 [TBL] [Abstract][Full Text] [Related]
30. ERK mediated upregulation of death receptor 5 overcomes the lack of p53 functionality in the diaminothiazole DAT1 induced apoptosis in colon cancer models: efficiency of DAT1 in Ras-Raf mutated cells. Thamkachy R; Kumar R; Rajasekharan KN; Sengupta S Mol Cancer; 2016 Mar; 15():22. PubMed ID: 26956619 [TBL] [Abstract][Full Text] [Related]
31. Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells. Fitzgerald TL; Lertpiriyapong K; Cocco L; Martelli AM; Libra M; Candido S; Montalto G; Cervello M; Steelman L; Abrams SL; McCubrey JA Adv Biol Regul; 2015 Sep; 59():65-81. PubMed ID: 26257206 [TBL] [Abstract][Full Text] [Related]
32. The transcription factor NFAT1 induces apoptosis through cooperation with Ras/Raf/MEK/ERK pathway and upregulation of TNF-α expression. Robbs BK; Lucena PI; Viola JP Biochim Biophys Acta; 2013 Aug; 1833(8):2016-28. PubMed ID: 23583303 [TBL] [Abstract][Full Text] [Related]
33. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy. Moretti L; Yang ES; Kim KW; Lu B Drug Resist Updat; 2007; 10(4-5):135-43. PubMed ID: 17627865 [TBL] [Abstract][Full Text] [Related]
34. Tanshinone IIA inhibits gastric carcinoma AGS cells by decreasing the protein expression of VEGFR and blocking Ras/Raf/MEK/ERK pathway. Su CC Int J Mol Med; 2018 Apr; 41(4):2389-2396. PubMed ID: 29393362 [TBL] [Abstract][Full Text] [Related]
36. Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection. Zhang Q; Wei L; Yang H; Yang W; Yang Q; Zhang Z; Wu K; Wu J Cancer Lett; 2016 Feb; 371(1):107-16. PubMed ID: 26620707 [TBL] [Abstract][Full Text] [Related]
37. PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives. Asati V; Mahapatra DK; Bharti SK Eur J Med Chem; 2016 Feb; 109():314-41. PubMed ID: 26807863 [TBL] [Abstract][Full Text] [Related]
38. Anti-leukemia effect of perillyl alcohol in Bcr/Abl-transformed cells indirectly inhibits signaling through Mek in a Ras- and Raf-independent fashion. Clark SS; Zhong L; Filiault D; Perman S; Ren Z; Gould M; Yang X Clin Cancer Res; 2003 Oct; 9(12):4494-504. PubMed ID: 14555523 [TBL] [Abstract][Full Text] [Related]
39. Primary and acquired resistance of colorectal cancer cells to anti-EGFR antibodies converge on MEK/ERK pathway activation and can be overcome by combined MEK/EGFR inhibition. Troiani T; Napolitano S; Vitagliano D; Morgillo F; Capasso A; Sforza V; Nappi A; Ciardiello D; Ciardiello F; Martinelli E Clin Cancer Res; 2014 Jul; 20(14):3775-86. PubMed ID: 24812410 [TBL] [Abstract][Full Text] [Related]
40. Epidermal Growth Factor Receptor Signaling to the Mitogen Activated Protein Kinase Pathway Bypasses Ras in Pancreatic Cancer Cells. Lee S; Heinrich EL; Lu J; Lee W; Choi AH; Luu C; Chung V; Fakih M; Kim J Pancreas; 2016 Feb; 45(2):286-92. PubMed ID: 26262587 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]